QIAGEN OmicSoft and Biomedical Knowledge Base

Drug treatment, toxicology and target safety assessment using QIAGEN Ingenuity Pathway Analysis (IPA) and QIAGEN Omicsoft - Oct 26 2021

519 views
October 27, 2021
In this 90-minute training, users will learn how to do drug treatment, toxicology and target safety assessment related discoveries using QIAGEN Ingenuity Pathway Analysis (IPA) and QIAGEN Omicsoft Lands.

Using public data from GTEx (normal tissue), GEO, cancer collections and more, attendees will learn how to use Omicsoft Lands to:
• Investigate a drug target or biomarker expression across different normal tissues, disease conditions, treatments and more
• Correlate expression of 2 or more genes
• Identify a list of genes or biomarkers specific to treatment, disease, normal tissue, cell type and more

Using findings from peer-reviewed publications and other sources, attendees will learn how to use QIAGEN IPA to:
• Investigate the impact of targeting a gene/protein on different toxicological and biological functions
• Derive tox findings for a gene of interest from QIAGEN IPA’s knowledgebase
• Identify and study toxicity-related pathways, regulators and functions for an internal dataset or a public dataset
• Compare different drug treatments, other conditions or multi-omics data for novel discoveries

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...

1,899 views July 19, 2022

High-quality biomedical relationships knowledge is the cornerstone of modern...

QIAGEN OmicSoft and Biomedical Knowledge Base

QIAGEN OmicSoft trainings- 3 part series - Oct 20 (part 1)

890 views October 26, 2021

In three separate 60-minute trainings, attendees will learn how to use basic...

QIAGEN OmicSoft and Biomedical Knowledge Base

Expression data analysis using QIAGEN Omicsoft Studio - Sep 28 2021

824 views October 01, 2021

In this training, users will learn how to generate downstream outputs such...